Brought to you by 
Sepracor raises $500mm through convertible debt placement
04 Jan 2002
Executive Summary
Chiral drug company Sepracor grossed $500mm in a private placement of 5.75% convertible subordinated notes due 2006. It raised $400mm initially and an additional $100mm through an overallotment.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Chiral Chemistry
Deal Status
- Final
Deal Type
-
Financing
- Convertible Debt
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com